Discover the significance of PIRA in multiple sclerosis (MS) and how pharmacists enhance early detection and patient care in MS management.
Aimee M. Banks, PharmD, BCPS, MSCS
Advertisement
Articles by Aimee M. Banks, PharmD, BCPS, MSCS
Understanding the Multiple Sclerosis Disease Continuum and the Consequences of Untreated Progression
Explore innovative strategies for identifying and managing multiple sclerosis through expert insights on biomarker-driven care and clinical practices.
Explore how pharmacists enhance access to care for multiple sclerosis patients, tackling barriers in diagnosis, treatment, and patient education.
Pharmacists enhance care for multiple sclerosis patients by improving access, education, and adherence, ensuring effective treatment through collaboration with healthcare teams.
Advertisement
Latest Updated Articles
The Pharmacist as a Central Liaison in Interdisciplinary Multiple Sclerosis CarePublished: January 28th 2026 | Updated:
Navigating Access, Cost, and Education in Multiple Sclerosis TreatmentPublished: January 27th 2026 | Updated:
Pharmacist Best Practices in Early Multiple Sclerosis Detection and Disability IdentificationPublished: January 30th 2026 | Updated:
Q&A: Strengthening Multiple Sclerosis Care Through Embedded Clinical Pharmacy CollaborationPublished: January 22nd 2026 | Updated:
- Pharmacists Reaching Out in Multiple Sclerosis: Integrating Digital Technology to Support Patient Care
Published: May 13th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5